40 research outputs found

    Preclinical mouse models for BRCA1-associated breast cancer

    Get PDF
    A substantial part of all hereditary breast cancer cases is caused by BRCA1 germline mutations. In this review, we will discuss the insights into BRCA1 functions that we obtained from mouse models with conventional and conditional mutations in Brca1. The most advanced models closely resemble human BRCA1-related breast cancer and may therefore be useful for addressing clinically relevant questions

    Small molecule activators of the Trk receptors for neuroprotection

    Get PDF
    The neurotophin signaling network is critical to the development and survival of many neuronal populations. Especially sensitive to imbalances in the neurotrophin system, cholinergic neurons in the basal forebrain are progressively lost in Alzheimer's disease. Therapeutic use of neurotrophins to prevent this loss is hampered, however, by a number of pharmacological challenges. These include a lack of transport across the blood-brain barrier, rapid degradation in the circulation, and difficulty in production. In this review we discuss the evidence supporting the neurotrophin system's role in preventing neurodegeneration and survey some of the pharmacological strategies being pursued to develop effective therapeutics targeting neurotrophin function

    Role of neurotrophin signalling in the differentiation of neurons from dorsal root ganglia and sympathetic ganglia

    Full text link

    Promoter usage of BRCA1-IRIS

    No full text

    Promoter usage of BRCA1-IRIS

    No full text

    Genetic evidence for selective neurotrophin 3 signalling through TrkC but not TrkB in vivo

    Get PDF
    Neurotrophins control neuronal survival in a target-derived manner during the period of naturally occurring cell death in development. The specificity of this mechanism has been attributed to a restricted spatio-temporal expression of neurotrophin ligands in target tissues, as well as a selective expression of their cognate tyrosine kinase (Trk) receptors in different neuronal subpopulations. However, several in vitro and in vivo studies of null mutant mice have suggested that neurotrophin 3 (NT3) also signals through the non-preferred TrkB receptor. In this study, we have directly addressed the in vivo preference of NT3 to signal through TrkB or TrkC, by crossing the NT3 knock-in mice (BDNF(NT3/NT3) mice) with the TrkB- or TrkC-null mutant mice. We find that TrkB is dispensable, whereas TrkC is required for the neuronal rescue by the NT3 allele in the brain-derived neurotrophic factor- and NT3-dependent cochleovestibular system. Our results show that NT3 maintains survival of cells as well as target innervation only through interactions with TrkC in vivo. TrkB and TrkC receptors are thus not functionally redundant for NT3, even when coexpressed in neurons of the cochleovestibular system
    corecore